Buy & Sell Indo Acidatama Tbk - SRSN Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp1.26T | +8.89% |
| Cost of Revenue | Rp944.28B | -1.85% |
| Gross Profit | Rp312.08B | +62.76% |
| General Expenses, Depreciation, Interest | Rp191.73B | +29.16% |
| Operating Profit | Rp120.35B | +177.96% |
| Other Income | -Rp19.71B | +43.43% |
| EBT | Rp100.64B | +240.49% |
| Taxes | -Rp23.29B | +230.06% |
| Net Income | Rp77.35B | +243.76% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp1.05T | -7.31% |
| Total Liabilities | Rp242.59B | -38.87% |
| Total Equity | Rp809.82B | +9.65% |
| Total Liabilities & Total Equity | Rp1.05T | -7.31% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp255.84B | -256.54% |
| CF from Investment | Rp34.18B | +428.23% |
| CF from Financing | Rp220.05B | -240.6% |
| Net Cash Flow | Rp1.61B | -111.99% |